TNF and discoid lupus erythematosus: Notably, a recent phase 2 trial found that intradermal injection of a TNF-neutralizing agent, etanercept, as opposed to traditional systemic injection, induced remission in DLE (61, 62), supporting the conclusion that the local presence of TNF in the skin lesion is pathogenic in DLE.